Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingwen granules for pediatric Mycoplasma pneumonia
ChiCTR2300078207Phase 4Not yet recruiting
- Sponsor
- Hebei Yiling Hospital
- Start
- Dec 2023
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lianhua Qingwen in Mycoplasmal pneumonia (2 arms), sponsored by Hebei Yiling Hospital. Primary endpoint: Relief rate of main symptoms. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
Lianhua Qingwen
03
Conditions
Mycoplasmal pneumonia
Beyond the preview
Go deeper on ChiCTR2300078207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078207.